Metformin for infants after brain injury from HIE
Treatments studied
Part of Brain & nervous system, Heart & circulation, Injuries & trauma clinical trials.
This trial tests whether metformin, a common diabetes medicine, can help heal brain injury in infants who had HIE (lack of oxygen at birth) and were treated with cooling. It aims to see if the drug is safe and possible to give to babies between 3 and 6 months old.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your baby is between 3 and 6 months old when starting the study drug.
- Your baby was born after 35 weeks of pregnancy, had HIE (lack of oxygen around birth), and received cooling treatment.
- A brain MRI taken after cooling showed signs of injury from the lack of oxygen.
- Your family speaks either English or Spanish.
- Your baby does not have a known genetic disorder, liver or kidney disease, or a very low weight (below the 10th percentile).
- Your baby is not taking medicines that could interfere with the study drug, and you are not breastfeeding while taking metformin.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial is for newborn babies who had an oxygen shortage around birth and now have severe brain injury. It aims to test approaches that may help improve outcomes after this kind of early-life brain damage.
This trial tests whether adding sildenafil to standard cooling treatment helps newborns who had a lack of oxygen to the brain. It aims to see if this combination can reduce brain damage and improve outcomes.
This early study tests whether giving melatonin to newborns with hypoxic-ischemic encephalopathy (brain injury from not enough oxygen around birth) can help protect the brain while they are cooled (therapeutic hypothermia). It may be most relevant if your baby shows early brain-injury signs and meets specific blood test and birth-history timing criteria.
This trial studies whether RLS-0071 is safe and can help some newborns with moderate or severe hypoxic-ischemic encephalopathy (HIE), a brain injury caused by low oxygen around birth. Babies in the study also receive standard whole-body cooling (therapeutic hypothermia), and the researchers will watch for side effects and early signs of benefit.
This study looks at how children who had a brain injury around birth (called hypoxic-ischaemic encephalopathy, or HIE) are doing in school and daily life, compared to children without that history. It aims to understand the long-term effects and support needs.
This study looks at a special blood marker in full-term newborns who had brain injury from lack of oxygen during birth. It aims to help doctors better understand and treat this condition.
Hear when a new Hypoxic-Ischemic Encephalopathy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.